A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection

Transfusion

Volumn 45, Issue 4, 2005, Pages 604-612

  Heuft, Hans Gert ^a   Goudeva, Lilia ^b   Pulver, Nicole ^b   Grigull, Lorenz ^b   Schwella, Nimrod ^b   Blasczyk, Rainer ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANOCYTE13; GRANOCYTE34; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; APHERESIS; ARTICLE; BACKACHE; BLOOD DONOR; BONE PAIN; CELL MOTILITY; DOSE RESPONSE; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; HUNGER; INSOMNIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NAUSEA; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL TRANSFUSION; NORMAL HUMAN; RESTLESSNESS; SCHOOL CHILD; SIDE EFFECT; STOMACH PAIN; SWEATING; THIRST; TRANSFUSION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 17044417665     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.04240.x     Document Type: Article

References (32)

1. Stroncek DF, Yau YY, Oblitas J, Leitmann SF. Administration of G-CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone. Transfusion 2001;4:1037-44.
2. Stroncek DF, Matthews CL, Follmann D, Leitman SF. Kinetics of G-CSF-induced granulocyte mobilization in healthy subjects: effects of route of administration and addition of dexamethasone. Transfusion 2002;42:597-602.
3. Caspar CB, Seger RA, Burger J, Gmür J. Effective stimulation of donors for ganulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
4. de Haas M, Kerst JM, van der Schoot CE, et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994;84:3885-94.
5. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions, kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion 1998;38:713-21.
6. Liles WC, Huang JF, Llewellyn C, et al. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, seperately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997;37:182-7.
7. Liles WC, Rodger E, Dale DC. Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosing. Transfusion 2000;40:642-4.
8. Price TH, Bowden RA, Boeckh M, et al. Phase 1/11 trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000;95:3302-9.
9. Worel N, Kurz M, Peters C, Höcker P. Serial granulocyte apheresis under daily administration of rHuG-CSF: effects on peripheral blood counts, collection efficiency, and yield. Transfusion 2001;41:390-5.
10. Adkins DR, Ali S, Despotis G, Dynis M, Goodnough LT. Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte-colony-stimulating factor. Transfusion 1998;38:557-64.
11. Adkins D, Spitzer G, Johnston M, et al. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 1997;37:737-48.
12. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
13. Adkins DR, Goodnough LT, Shenoy S, et al. Effect of leucocyte compatibility on neutrophil increment after transfusion of granulocyte colony stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 2000;95:3605-12.
14. Jendiroba DB, Lichtiger B, Anaissie E, et al. Evaluation and comparison of three mobilization methods for the collection of granulocytes. Transfusion 1998;38:722-88.
15. McCullough J, Clay M, Herr G, Smith J, Stroncek D. Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors. Transfusion 1999;39:1136-40.
16. Price TH. Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions. Curr Opin Hematol 1998;5:391-5.
17. Hübel K, Carter RA, Liles WC, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion 2002;42:1414-21.
18. Van Burik JH, Weisdorf DJ. Is it time for a new look at granulocyte transfusions? Transfusion 2002;42:1393-5.
19. Höglund M, Hakansson L, Venge P. Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers. Eur J Haematol 1997;8:195-202.
20. Kubota N, Orita T, Hatttori K, et al. Structural characterization of natural and recombinant granulocyte colony stimulating factors. J Biochem 1990;107:486-92.
21. Kishita M, Motojima H, Oh-eda M, et al. Stability of granulocyte colony stimulating factor in serum. Clin Rep 1992;26:221.
22. Watts MJ, Addison I, Long SG, et al. Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers. Br J Haematol 1997;98:474-9.
23. Heuft HG, Goudeva L, Sel S, Blasczyk R. Equivalent mobilization and collection of granulocytes for transfusion after administration of 3 μg/kg glycosylated G-CSF plus dexamethasone versus 12 μg/kg glycosylated G-CSF alone. Transfusion 2002;42:928-34.
24. Heuft HG, Goudeva L, Blasczyk R. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors. Ann Hematol 2004;83:279-85.
25. Heuft HG, Goudeva L, Schwella N, Blasczyk R. Collection of two consecutive neutrophil concentrates for transfusion from donors mobilized with glycosylated G-CSF plus dexamethasone. Transfusion 2004;44:750-8.
26. Scientific Committee of the German Medical Association. Guidelines to the preparation of blood and blood components and to the use of blood products. Köln: Deutscher Ärzte-Verlag; 2000.
27. Pollmächter T, Korth C, Schreiber W, Hermann D, Mullington J. Effects of repeated administration of granulocyte-colony-stimulating factor on neutrophil counts, plasma cytokine, and cytokine receptor levels. Cytokine 1996;8:799-803.
28. Kerst JM, de Haas M, van der School CE, et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265-72.
29. Yong KL. Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). Br J Haematol 1996;94:40-7.
30. Kerst JM, van de Winkel JG, Evans AH, et al. Granulocyte colony-stimulating factor induces hFc gamma R1 (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood 1993;81:1457-64.
31. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitive relationships between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
32. Peters C, Minkov M, Matthes-Martin S, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol 1999;106:689-96.